Rhiannon N. Hardwick

1.9k citations

33 papers · 1.4k indexed · h-index 22

Co-authors: Nathan J. Cherrington April D. Lake Mark J. Canet Craig D. Fisher Petr Novák John Clarke Walter T. Klimecki Nathan D. Pfeifer
Topics: Liver Disease Diagnosis and Treatment (18 papers)Drug Transport and Resistance Mechanisms (15 papers)Liver Diseases and Immunity (6 papers)
Cited by: Hepatology Pharmacology Epidemiology
Journals: Journal of Hepatology Journal of Pharmacology and Experimental Therapeutics The Annual Review of Pharmacology and Toxicology
Partner nations: United States United Kingdom Czechia

In The Last Decade

Rhiannon N. Hardwick

33 papers receiving 1.4k citations

Peers

Countries citing papers authored by Rhiannon N. Hardwick

Since Specialization

Citations

This map shows the geographic impact of Rhiannon N. Hardwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhiannon N. Hardwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhiannon N. Hardwick more than expected).

Fields of papers citing papers by Rhiannon N. Hardwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhiannon N. Hardwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhiannon N. Hardwick. The network helps show where Rhiannon N. Hardwick may publish in the future.

Co-authorship network of co-authors of Rhiannon N. Hardwick

This figure shows the co-authorship network connecting the top 25 collaborators of Rhiannon N. Hardwick. A scholar is included among the top collaborators of Rhiannon N. Hardwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhiannon N. Hardwick. Rhiannon N. Hardwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Two-Way Interaction between Methotrexate and the Gut Microbiota of Male Sprague–Dawley Rats 2020 ·Journal of Proteome Research ·Marine P. M. Letertre,(unknown),(unknown),Alexandros Pechlivanis,Julie A. K. McDonald,Rhiannon N. Hardwick,Nathan J. Cherrington,Muireann Coen,Jeremy K. Nicholson,Lesley Hoyles,Jonathan R. Swann,Ian D. Wilson	47
2	Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis 2019 ·Toxicology and Applied Pharmacology ·April D. Lake,Rhiannon N. Hardwick,Christopher P. Leamon,Philip S. Low,Nathan J. Cherrington	4
3	Altered Regulation of Hepatic Efflux Transporters Disrupts Acetaminophen Disposition in Pediatric Nonalcoholic Steatohepatitis 2015 ·Drug Metabolism and Disposition ·Mark J. Canet,Matthew D. Merrell,Rhiannon N. Hardwick,Amy M. Bataille,Sarah N. Campion,(unknown),Stavra A. Xanthakos,José E. Manautou,Hassan H. A‐Kader,Robert P. Erickson,Nathan J. Cherrington	51
4	Fetal exposure to arsenic results in hyperglycemia, hypercholesterolemia, and nonalcoholic fatty liver disease in adult mice 2014 ·(unknown),(unknown),(unknown),Rhiannon N. Hardwick,Nathan J. Cherrington,Todd D. Camenisch	19
5	Increased Susceptibility to Methotrexate-Induced Toxicity in Nonalcoholic Steatohepatitis 2014 ·Toxicological Sciences ·Rhiannon N. Hardwick,John Clarke,April D. Lake,Mark J. Canet,Tarun Anumol,(unknown),Matthew D. Merrell,Michael Goedken,Shane A. Snyder,Nathan J. Cherrington	48
6	Systems Level Metabolic Phenotype of Methotrexate Administration in the Context of Non-alcoholic Steatohepatitis in the Rat 2014 ·Toxicological Sciences ·Michael Kyriakides,Rhiannon N. Hardwick,Zhaosheng Jin,Michael Goedken,Elaine Holmes,Nathan J. Cherrington,Muireann Coen	16
7	Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression 2014 ·Journal of Pharmacology and Experimental Therapeutics ·John Clarke,Rhiannon N. Hardwick,April D. Lake,Mark J. Canet,Nathan J. Cherrington	37
8	Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models 2014 ·Drug Metabolism and Disposition ·Mark J. Canet,Rhiannon N. Hardwick,April D. Lake,Anika L. Dzierlenga,John Clarke,Nathan J. Cherrington	57
9	Synergistic interaction between genetics and disease on pravastatin disposition 2014 ·Journal of Hepatology ·John Clarke,Rhiannon N. Hardwick,April D. Lake,Andrew J. Lickteig,Michael Goedken,Curtis D. Klaassen,Nathan J. Cherrington	45
10	Renal Xenobiotic Transporter Expression is Altered in Multiple Experimental Models of Nonalcoholic Steatohepatitis 2014 ·Drug Metabolism and Disposition ·Mark J. Canet,Rhiannon N. Hardwick,April D. Lake,Anika L. Dzierlenga,John Clarke,Michael Goedken,Nathan J. Cherrington	14
11	The Adaptive Endoplasmic Reticulum Stress Response to Lipotoxicity in Progressive Human Nonalcoholic Fatty Liver Disease 2013 ·Toxicological Sciences ·April D. Lake,Petr Novák,Rhiannon N. Hardwick,(unknown),Fei Zhao,Walter T. Klimecki,Nathan J. Cherrington	106
12	Hepatic Basolateral Efflux Contributes Significantly to Rosuvastatin Disposition II: Characterization of Hepatic Elimination by Basolateral, Biliary, and Metabolic Clearance Pathways in Rat Isolated Perfused Liver 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Nathan D. Pfeifer,Arlene S. Bridges,Brian C. Ferslew,Rhiannon N. Hardwick,Kim L. R. Brouwer	28
13	Basolateral Uptake of Nucleosides by Sertoli Cells Is Mediated Primarily by Equilibrative Nucleoside Transporter 1 2013 ·Journal of Pharmacology and Experimental Therapeutics ·David Klein,Kristen K. Evans,Rhiannon N. Hardwick,William H. Dantzler,Stephen H. Wright,Nathan J. Cherrington	31
14	Arsenite activates NFκB through induction of C-reactive protein 2012 ·Toxicology and Applied Pharmacology ·Ingrid L. Druwe,(unknown),(unknown),Rhiannon N. Hardwick,Todd D. Camenisch,Richard R. Vaillancourt	24
15	Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver Disease 2012 ·Drug Metabolism and Disposition ·Rhiannon N. Hardwick,(unknown),Vijay R. More,April D. Lake,Zhenqiang Lu,José E. Manautou,Angela L. Slitt,Nathan J. Cherrington	93
16	Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease 2012 ·Drug Metabolism and Disposition ·Mark J. Canet,Rhiannon N. Hardwick,April D. Lake,Michael J. Kopplin,George L. Scheffer,Walter T. Klimecki,A. Jay Gandolfi,Nathan J. Cherrington	21
17	Molecular Mechanism of Altered Ezetimibe Disposition in Nonalcoholic Steatohepatitis 2011 ·Drug Metabolism and Disposition ·Rhiannon N. Hardwick,Craig D. Fisher,(unknown),Mark J. Canet,Nathan J. Cherrington	52
18	Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease 2011 ·Drug Metabolism and Disposition ·Rhiannon N. Hardwick,Craig D. Fisher,Mark J. Canet,George L. Scheffer,Nathan J. Cherrington	113
19	Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease 2011 ·Drug Metabolism and Disposition ·April D. Lake,Petr Novák,Craig D. Fisher,Jonathan P. Jackson,Rhiannon N. Hardwick,Dean Billheimer,Walter T. Klimecki,Nathan J. Cherrington	124
20	Genetic variation in the mouse model of Niemann Pick C1 affects female, as well as male, adiposity, and hepatic bile transporters but has indeterminate effects on caveolae 2011 ·Gene ·David Jelínek,(unknown),(unknown),Rhiannon N. Hardwick,Nathan J. Cherrington,Robert P. Erickson	9

About Rhiannon N. Hardwick

Rhiannon N. Hardwick is a scholar working on Hepatology, Oncology and Epidemiology, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Drug Transport and Resistance Mechanisms (15 papers) and Liver Diseases and Immunity (6 papers). The work is most often cited by research in Hepatology (267 citations), Pharmacology (269 citations) and Epidemiology (724 citations). Rhiannon N. Hardwick has collaborated with scholars based in United States, United Kingdom and Czechia. Frequent co-authors include Nathan J. Cherrington, April D. Lake, Mark J. Canet, Craig D. Fisher, Petr Novák, John Clarke, Walter T. Klimecki, Nathan D. Pfeifer, George L. Scheffer and Kim L. R. Brouwer. Their work appears in journals such as Journal of Hepatology, Journal of Pharmacology and Experimental Therapeutics and The Annual Review of Pharmacology and Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact